Intelligent CpG nanoplatforms for targeted cancer immunotherapy and immune remodeling
Frontiers in Pharmacology · 12.06.2026 · 17
DOI: 10.3389/fphar.2026.1826929 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 12.06.2026. Verfasst von Huixia Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: The People's Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, Danyang, Jiangsu Province, China. Die Arbeit nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
CpG oligonucleotides are potent immunoadjuvants that hold great promise for cancer immunotherapy, but their clinical use is limited by in vivo instability, off-target toxicity, and poor tumor targeting. Intelligent nanoplatforms offer effective solutions to these challenges by protecting CpG, improving delivery precision, and enabling on-demand cargo release. This review summarizes four major design strategies: biomimetic/biohybrid systems for targeted delivery, stimuli-responsive nanocarriers for controlled release, structural engineering for enhanced immune activation, and combinatorial therapy for systemic immune remodeling. These nanoplatforms not only improve CpG stability and tumor-targeting capability but also reshape the tumor immune microenvironment, convert “cold” tumors to “hot” phenotypes, and induce long-term immune memory. We highlight the design principles, action mechanisms, key advantages, and inherent limitations of current intelligent CpG-based nanosystems, aiming to advance the development and clinical translation of CpG nanotherapeutics for more effective and personalized cancer immunotherapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The People's Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, Danyang, Jiangsu Province, China.
- School of Pharmacy, Nantong University, Nantong, Jiangsu Province, China.
Zitieren
APA
Wang, H., Zhang, Y., & Zhou, M. (2026). Intelligent CpG nanoplatforms for targeted cancer immunotherapy and immune remodeling. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1826929
Vancouver
Wang H, Zhang Y, Zhou M. Intelligent CpG nanoplatforms for targeted cancer immunotherapy and immune remodeling. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1826929
BibTeX
@article{Wang2026,
author = {Wang, Huixia and Zhang, Yangming and Zhou, Mengjiao},
title = {Intelligent CpG nanoplatforms for targeted cancer immunotherapy and immune remodeling},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1826929}
}
EUVIMED